Autor: |
Larrivée-Aboussafy C; Development Science and Technology, Pfizer Inc., Eastern Point Road, Groton, Connecticut 06340, USA., Jones BP, Price KE, Hardink MA, McLaughlin RW, Lillie BM, Hawkins JM, Vaidyanathan R |
Jazyk: |
angličtina |
Zdroj: |
Organic letters [Org Lett] 2010 Jan 15; Vol. 12 (2), pp. 324-7. |
DOI: |
10.1021/ol9026599 |
Abstrakt: |
1,8-Diazabicyclo[5.4.0]undec-7-ene (DBU) has been found to catalyze the amidation of acyl imidazoles. The rate acceleration is especially evident with traditionally unreactive, electron-deficient anilines. DBU is readily available and offers safety and cost advantages over more commonly employed catalysts such as 1-hydroxybenzotriazole. |
Databáze: |
MEDLINE |
Externí odkaz: |
|